Generics 1

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Efmoroctocog alfa manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Sweden

Clear all

1 products found

efmoroctocog alfa

Vials, injection Upon request

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #13160
It is an international biopharmaceutical company focused on rare diseases. They are dedicated to providing access to innovative treatments that transform the lives of people with rare diseases. They focus on two therapeutic areas – hematology and immunology – and also have a portfolio of specialty care products. They have in-house capabilities that stretch from late-stage R&D, biologics manufacturing and supply, to patient access and distribution.

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.